NFKB1 and central nervous system cancer: Using specific inhibitors to inhibit the activation of NF‐κB could inhibit glioma growth.1 It was reported that NF‐κB activation in response to chemotherapeutic agents protected U87 glioma cells in vitro.7 The transcription factor NF‐κB plays a critical role in inflammation, oncogenesis, and tumor progression.